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Abstract
Background: In vivo determination of regional pulmonary blood flow (PBF) is a valuable tool for the
evaluation of many lung diseases. In this study, the use of 68Ga-DOTA PET for the in vivo quantitative
determination of regional PBF is proposed. This methodology was implemented and tested in healthy pigs
and validated using fluorescent microspheres. The study was performed on young large white pigs (n = 4).
To assess the reproducibility and consistency of the method, three PET scans were obtained for each animal.
Each radiotracer injection was performed simultaneously to the injection of fluorescent microspheres. PBF
images were generated applying a two-compartment exchange model over the dynamic PET images. PET and
microspheres values were compared by regression analysis and Bland–Altman plot.
Results: The capability of the proposed technique to produce 3D regional PBF images was demonstrated.
The correlation evaluation between 68Ga-DOTA PET and microspheres showed a good and significant
correlation (r = 0.74, P < 0.001).
Conclusions: Assessment of PBF with the proposed technique allows combining the high quantitative accuracy of
PET imaging with the use of 68Ga/68Ge generators. Thus, 68Ga-DOTA PET emerges as a potential inexpensive method
for measuring PBF in clinical settings with an extended use.
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Background
In vivo determination of regional pulmonary blood flow
(PBF) is a valuable tool for the evaluation of many lung
diseases like chronic obstructive pulmonary disease
(COPD), pulmonary hypertension (PH), or pulmonary
embolism. Different imaging modalities have been sug-
gested to accomplish this task like magnetic resonance
imaging (MRI) [1, 2], scintigraphy [3], single photon
emission computed tomography (SPECT) [4], computed
tomography (CT) [5], or positron emission tomography
(PET) [6, 7].
Determination of blood flow with PET using 15O-labeled
water is considered the clinical standard [6, 8–10].
However, this technique has very low availability due
to the short half-life of 15O (2.03 min) that requires
an on-site cyclotron for its production [11]. In con-
trast to cyclotrons, 68Ge/68Ga generators are cost-
effective systems that provide 68Ga radionuclide on
demand [12]. 68Ga has a half-life (68 min) suitable for
clinical studies and can be used to label radiopharma-
ceuticals with low molecular weight. Similar to
gadolinium-chelated compounds used in MRI [13], a
gallium-68-chelated compound has been suggested by
Autio et al. [14] to study blood flow in a preliminary
study in rats.
Blood flow measurements with microspheres (MS)
is considered the gold standard [15] for the ex vivo
validation of different imaging techniques in animals
[9, 16, 17]. The MS technique can provide accurate
quantitative regional PBF after removing the lung and
processing individual tissue samples.
The purpose of this study was to evaluate the feasibility
of using a diffusible 68Ga-chelated agent, 68Ga-DOTA, for
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in vivo PET imaging of regional PBF and to validate the
results using fluorescent MS in pigs.
Methods
Synthesis of 68Ga-DOTA
68Ga (t½ = 68 min) was available from a
68Ge/68Ga gener-
ator system (ITG Isotope Technologies Garching GmbH,
Germany). 68Ga was eluted with 4 ml of 0.05 M hydro-
chloric acid. 68Ga was added to a solution containing
200 μg of DOTA (1,4,7,10-Tetraazacyclododecane-
1,4,7,10-tetraacetic acid) dissolved in 0.25 M HEPES buf-
fer pH = 4.5. The mixture was heated at 95 °C for 20 min.
Finally, 90 μl of NaOH 1 M and 5 ml of NaCl 0.9% were
added yielding 68Ga-DOTA with a radionuclide purity at
radio-HPLC >95% (see Additional file 1).
Animal preparation
This study was conducted according to the guidelines of
the current European Directive and Spanish legislation
and approved by the regional ethical committee for ani-
mal experimentation. The study was performed on
young large white pigs (n = 4, mean weight 41.9 ± 5.9 kg)
of either sex. To perform the imaging acquisition, ani-
mals were sedated with a combination of ketamine
15 mg/kg, xylazine 2 mg/kg, and midazolam 0.5 mg/kg.
Animals were kept anesthetized by intravenous infusion
of ketamine 4 mg/kg/h and midazolam 0.5 mg/kg/h in
saline. The animals were intubated and mechanically
ventilated in pressure support ventilation mode with
mean fractional concentration of oxygen in inspired gas
of 35–40%, tidal volume of 8 ml kg−1, and positive end-
expiratory pressure ranged from 7 to 9 cm H2O. Re-
spiratory rate was ≈18 bpm.
A 7-French pulmonary artery catheter (Swan–Ganz;
Edwards Lifesciences World Trade Co. Ltd, Irvine, CA,
USA) was inserted through the right external jugular
vein using an 8-French introducer sheath (Medtronic,
Minneapolis, MN, USA) for continuous pulmonary
artery pressure monitoring, MS injection, and blood
sample extraction. The Swan–Ganz catheter tip was
located in the main pulmonary artery. Additionally, ECG
and pulsioximetry were monitored during the entire
experiment.
Image acquisition
PET/CT images were acquired using a Gemini TF-64
scanner (Philips Healthcare, Best, The Netherlands).
Animals were placed supine, and three 68Ga-DOTA PET
scans were obtained under similar physiological condi-
tions for each animal with 30-min interperiod between
consecutive scans to allow for physical and biological
decay. However, some remaining activity was accumu-
lated in subsequent scans as is schematically shown in
Fig. 1. In order to measure the background activity, a
60-s frame was acquired prior to the radiotracer injec-
tion and included in the kinetic modeling. No further
background corrections were required. Each scan con-
sisted in a low dose CT scan (120 kV, 80 mA) followed
by a 10-min list mode PET acquisition in a single bed
position covering 18 cm of axial extension. The radio-
tracer prepared in 7 ml volume was infused with a pump
at a rate of 0.2 ml/s (35 s injection) through the marginal
ear vein (66 ± 33 MBq). PET scans were started 1 min
prior to the radiotracer injection. Each PET acquisition
was reconstructed in 41 consecutive frames (1 × 60, 24 ×
5, 6 × 10, 3 × 20, 4 × 30, and 3 × 60s). 3D-RAMLA recon-
struction algorithm was used in all cases producing
images with a voxel size of 4 × 4 × 4 mm3.
Each radiotracer injection was performed simultan-
eously to the injection of 15-μm fluorescent MS (Fluoro-
Spheres®, Molecular probes, Eugene, OR, USA). Each
MS injection consisted of 5 × 105 beads diluted into
10 ml of saline containing 0.01% Tween 80. The MS
were manually injected over ~60 s directly into the right
atrium via the Swan–Ganz catheter. A different MS
color was used on each of the three injections provided
to the same animal including green (λ = 450/480 nm),
yellow (λ = 515/534 nm), and red-orange (λ = 565/
580 nm). Immediately before MS dilution, the vial
was vigorously vortexed for 15 s, sonicated for 4 min,
Fig. 1 Timeline of the protocol followed for each animal and schematics of the radiotracer accumulation in subsequent scans
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and vortexed again for additional 15 s. Reference
blood samples were drawn from the pulmonary artery
through the Swan–Ganz into a heparinized syringe at
a rate of 5 ml/min (for 3 min) with an automated
syringe pump (Harvard PHD 22/2000 Advance Syr-
inge Pump, Harvard Apparatus), starting 1 min before
MS injection. Additionally, another blood sample was
taken from the pulmonary artery for hematocrit
measurement.
PET data analysis
PBF derived from MRI typically uses a single compart-
ment model as the acquisition is obtained during one
breath-hold and extravasation can be neglected. How-
ever, our PET data is acquired in free-breathing during
several minutes and extravasation becomes a relevant
factor. Therefore, the use of two-tissue compartments
was considered to account for the capillary bed and the
interstitial volume. In this way, parametric PBF images
(PBFPET) were generated voxelwise applying a two-
compartment exchange model (2CXM) [18] over the dy-
namic PET images. This model considers the plasma
volume of the lung capillary bed as the central compart-
ment which occupies a fractional volume vp, with a
tracer concentration Cp, and the interstitial volume as
the peripheral compartment which occupies a fractional
volume ve with a tracer concentration Ce (see Fig. 2).
The exchange rate between the two compartments is de-
scribed by the permeability-surface product (PS). Thus,
tracer concentrations over time (t) in both
compartments are explained by their mass balance equa-








¼ PSCp tð Þ−PSCe tð Þ ð2Þ
where Ca is the radiotracer concentration in the arterial
plasma (arterial input function) and Fp is the pulmonary
plasma flow. Tissue tracer concentration is the sum of
concentrations in plasma and interstitial space weighted
by each particular fractional volume (see Eq. 3).
Ct tð Þ ¼ vpCp tð Þ þ veCe tð Þ ð3Þ
This set of differential equations can be solved as the
convolution of Ca with the impulse response function
(IRF)
Ct tð Þ ¼ Ca t−δð Þ⊗IRF tð Þ; ð4Þ
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Therefore, the implemented 2CXM model contains
four fit parameters including vp, ve, Fp, and PS. The most
relevant parameter for our purpose is the pulmonary
plasma flow (Fp), which can be converted into the





where HT represents the hematocrit value.
It can be noticed that the arterial input function
employed for the analysis is delayed δ seconds with re-
spect to the voxel time-activity curves (TACs) as it was
derived from the right ventricle, and there is some delay
until it reach the lung capillaries. A delay of 2 s was
used. A transit time of 4 s from the right to the left ven-
tricles was observed that further justify the chosen delay
value. The same value was used in other studies with
15O-labeled water [9]. The delayed AIFs were interpo-
lated to match PET measurement times.
The radiotracer flows from the pulmonary arteries to
the veins through the capillary bed and extravasates to the
interstitial space. Therefore, the radiotracer concentration
Fig. 2 Schematics of the 2CXM model. Radiotracer flows from the
arteries to the veins through the capillary bed and extravasates to
the interstitial space. PS is the permeability-surface product, Fp is
the plasma flow, Ca(t) is the radiotracer concentration in the arterial
plasma, Ce(t) is the radiotracer concentration in the interstitial
volume, and Cp(t) is the radiotracer concentration in the lung
capillary bed
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can be expressed in terms of the plasma concentration in
the arterial input, the plasma flow, the plasma volume, the
permeability–surface area product, and the interstitial vol-
ume. The arterial input function (AIF) (see Fig. 3a) was
obtained from the mean voxel value at each time point
within a small volume of interest (VOI) drawn inside the
right ventricle and was corrected by the pulmonary artery
hematocrit to obtain the radiotracer concentration in ar-
terial plasma.
The non-linear fit of the TAC of each voxel was per-
formed by a minimization of the sum of squares using a
modified Levenberg–Marquardt method for bound
constraints using a Python-coded customized software
including SciPy and NumPY libraries. Figure 3b shows
and exemplary fit to the average TAC of a large region
within the lung. PBF obtained at each voxel was cor-
rected by tissue density. The CT values were used to ob-
tain lung density values (tissue + blood) [19], assuming a
linear behavior between CT value and tissue density in
the range from air (−1024 HU, ρ = 1.225 × 10−3 g/cm3)
to water (0 HU, ρ = 1 g/cm3) [20, 21]. The blood contri-
bution was subtracted using the plasma fractional
volume obtained in the minimization process. Further
details are described in Additional file 1.
On each animal, right and left lungs were segmented
separately and each lung was divided into three transver-
sal regions (apical, medial, and basal) with the same axial
extension to facilitate regional comparison with the MS
measurements (see Fig. 4). The PBF for each region was
computed as the average PBF of those voxels with CT
values between −925 and 0 HU in order to reject large
vessels and airways. A morphological erosion image
filtering with 4 mm size was performed over the VOI of
the lung to avoid spillover contribution from the heart
or liver.
MS analysis
The MS analysis was based on existing protocols [22]
with minor modifications. In brief, the pigs were
sacrificed the day after PET scans were performed and
the lungs were extracted. The lungs were expanded to
try to recover anatomic references and make easier the
comparison between zones in PET and excised lungs. To
this purpose, the pig was sedated as previously described
and euthanized by an intravenous overdose of pentobar-
bital in supine position while intubated. The animal was
mechanically ventilated with similar conditions than the
in vivo experiments, the trachea was clamped at the end
of inspiration, and the lungs were extracted. An ex vivo
CT scan of them was performed to guide the registration
between in vivo images and post-mortem validation MS
analysis. Afterwards, the lungs were wrapped in a plastic
film and frozen at −20 °C. Finally, right and left lungs
were separated and individually divided into transversal
slices (1–2 cm thickness). The left lung of one of the an-
imals was improperly processed and excluded from the
final analysis.
For tissue processing, each lung piece was weighted
and immersed in a KOH 4 N solution (5 ml/g of tissue).
At the same time, each reference blood sample with-
drawn during the experiment was taken to 60 ml with
2% Tween 80, followed by addition of 14 ml of KOH
16 N. All samples were incubated at 37 °C with vigorous
shaking during 24–48 h.
After complete tissue digestion, samples were indi-
vidually filtered with negative pressure filtration. A
different filter (Nylon Net Filter 10 μm, Millipore)
was used for each sample. Each digested sample was
poured onto the filter, and the containing tube was
rinsed with ~20 ml of 2% Tween 80 to ensure the
collection of all the MS. Next, the filter was rinsed
with ~10 ml of buffer rinse solution (KH2PO4/
K2HPO4) to neutralize the pH of the nylon filter.
Each filter was immersed in 10 ml of cellosolve
acetate (2-ethoxyethyl acetate 98%, Sigma) and
stored in the dark for 2–3 h, until the complete dis-
solution of the MS polystyrene cover. The fluores-
cence of the resultant solution was measured with a
Fig. 3 a An example of TACs obtained for a large region of the lung (dots) and right ventricle (solid line). b TAC from the lung (dots) and fit to a
two-compartment exchange model (solid line)
Velasco et al. EJNMMI Research  (2017) 7:7 Page 4 of 9
Fluorescence Spectrometer (PerkinElmer LS 55) at
the emission/excitation wavelengths of 450 nm/
480 nm, 515 nm/534 nm, and 565 nm/580 nm for
the green, yellow, and red-orange MS, respectively.
Both emission and excitation slits were set at 5.0 nm
for every reading. Finally, the fluorescence intensities
of each sample were used to compute the PBF
(PBFMS) following the standard MS reference tech-
nique [23]. Each sample was assigned to one of the
lung six regions segmented in the parametric PBFPET
images. Samples out of the field of view were not
further analyzed. The PBF of each region was com-
puted adding the fluorescent and weight values of
the samples assigned to it.
Statistic analysis
PBFPET and PBFMS values were directly compared by re-
gression analysis. Regression through the origin (RTO)
was performed instead of ordinary least squares (OLS)
method as PBFPET values are forced to be non-negative,
which produce a positive bias at low PBF. Also, Pearson
correlation coefficient was estimated, and Bland–Altman
plot was used to assess agreement between PBFPET and
PBFMS results. All the measurements were statistically
considered as independent events as the MS results
showed high variability for measurements repeated on
the same animal, and a wide range of PBF values was




Physiological variables were stable during the scan.
Heart rate was 100 ± 16 bpm, mean pulmonary artery
pressure was always under 25 mmHg, and oxygen satur-
ation was over 98%. A hematocrit value of 0.3, similar to
the value used in other perfusion studies with varied
techniques, was used for all analyses.
Parametric PBF maps
Figure 5 shows examples of PBFPET images at different
axial slices, demonstrating the capability of this tech-
nique to produce 3D regional PBF. The images are fused
with their corresponding CT slices for visualization pur-
poses only. PBF values are displayed only for those vox-
els with CT values in the range from −925 to 0 HU. As
Fig. 4 Coronal view of an in vivo CT image indicating the
segmentation of the lungs performed for the regional validation
against MS. Regions 1–2, 3–4, and 5–6 correspond to the basal,
medial, and apical zones of the lungs, respectively
Fig. 5 Fused transverse parametric PBFPET and CT images at four different axial locations
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expected, the dorsal regions show higher PBF values
compared to ventral regions as a consequence of the
supine position of the animal during the imaging
sessions [24].
Comparison PBFPET versus PBFMS
Bland–Altman plot (Fig. 6) shows the evaluation of the
agreement between PBFPET and PBFMS including 57
samples. Measured bias was −2.19 ml min−1 g−1 and
limits of agreement (LoA) ranged from −12.06 to
7.69 ml min−1 g−1. A slight but significant (P = 0.0001
for the correlation between PBFPET − PBFMS differences
against PBFPET − PBFMS mean) trend to measurement
underestimation related with the increase in the PBF
value measured was also observed. However, as the
effect of this trend was low (r2 = 0.0485), no correction
was applied to the data.
The MS measurement corresponding to the blood
sample of the third scan in pig number 4 showed atyp-
ical and extremely low fluorescence values compared to
background level. As this can increase the probability of
measurement errors, the six points corresponding to this
scan were excluded from the analysis. Results of the
agreement without the data exclusion lead to a bias and
LoA of −3.51 ml min−1 g−1 and from −16.30 to 9.27,
respectively.
Evaluation of the correlation between PBFPET and
PBFMS including 57 samples is shown in Fig. 7. The
methods showed a good and significant correlation (r =
0.74, P < 0.001) when perfusion across all the measured
regions of the lung were evaluated and was maintained
when the evaluation was done by lung zones: r = 0.84 (P
< 0.001), r = 0.69 (P < 0.001), and r = 0.76 (P < 0.001) for
apical, medial, and basal zones, respectively. The good-
ness of fit worsens (r = 0.66, P < 0.001 for the entire lung;
r = 0.76, P < 0.001 for the apical; r = 0.13, P < 0.001 for
the medial; and r = 0.74, P < 0.001 for the basal zone)
when the correlation is performed without the exclusion
of the six points mentioned before, which is in line with
the possibility of measurement errors.
Discussion
In this study, the use of 68Ga-DOTA PET for the in vivo
quantitative determination of regional PBF is proposed.
The methodology required to perform these studies was
implemented and tested in healthy pigs. Finally, the in
vivo measurements of regional PBF were validated using
fluorescent MS. This is a reliable and easily implementa-
ble alternative to dynamic contrast enhanced MRI,
where quantification is very challenging due to the non-
lineal dependence of signal intensity with the
gadolinium-based contrast agent concentration [10].
This is even more important due to the fact that these
agents, either linear or macrocyclic, are under investiga-
tion for multiple results demonstrating their potential
accumulation in various tissues regardless of renal func-
tion [25]. Our alternative has a simpler implementation
and provides quantitative measures of the regional blood
flow compared to recent approaches using dual energy
CT imaging [26, 27]. Compared to other PET-based
alternatives such as 15O-water [7] or dissolved 13N2 [28]
that need an on-site cyclotron, our solution could be
potentially more widely available due to the introduction
of gallium generators in the field and the approval of
different gallium-chelated agents for human use. Our
local estimation cost is 100 euros per study includ-
ing proportional use of the generator, reactive
Fig. 6 Assessment of agreement between PBFPET and PBFMS. Apical
(triangle), medial (square), and basal (circle) regions are shown. The
solid lines represent the mean bias (−2.19 ml min−1 g−1), and the
dashed lines represent the 95% confidence interval (mean ± 1.96 SD)
Fig. 7 Correlation between PBFPET and PBFMS. Apical (triangle),
medial (square), and basal (circle) regions are shown. The dashed line
represents regression line to all the points. Regression line equations
are measured in ml min−1 g−1. Slopes for the regression analysis by
lung zones were 0.74, 0.96, and 0.79 for apical, medial, and basal
regions, respectively
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agents, and lab technicians. Compared to other nu-
clear medicine techniques such as 99mTc-macroaggre-
gated albumin [4], which also reflects true perfusion,
SPECT shows lower spatial resolution and longer
acquisition times.
We have demonstrated the capability of the proposed
technique to obtain in vivo 3D regional PBF. Compara-
tive PBFPET and PBFMS values in dorsal and ventral
regions were not obtained due to the difficulty to
achieve a good in vivo and ex vivo registration.
The results of this study show potential for 68Ga-
DOTA radiotracer in clinical practice for measuring
PBF. Pulmonary perfusion is an important variable for
understanding lung function, especially when it can be
described regionally. Such relevancy has allowed that the
advances in imaging techniques for lung perfusion and
perfusion distribution become an attractive tool for diag-
nosis and outcomes prediction and evaluation. For ex-
ample, differences in perfusion patterns measured by
dual CT [29, 30] are being proposed for diagnosis of PH
and even to differentiate pulmonary arterial hyperten-
sion (PAH) from chronic thromboembolic pulmonary
hypertension (CTEPH) [31]. Recently, Lau et al. [32]
showed using SPECT/CT that pulmonary pre-capillary
hypertension showed a redistribution of flow changing
the gravidity influence, which appears as a potential tool
for disease severity evaluation. Not only PH but also
other lung diseases such as COPD have shown alter-
ations in perfusion, which in this disease is related to
impaired pulmonary function indexes, appearing also
promising for severity evaluation.
The good correlation existing between PBFPET and
PBFMS (see Fig. 7) shows high potential for the deter-
mination of quantitative regional PBF in vivo and non-
invasively using 68Ga-DOTA PET. Noteworthy, the r
value and slope obtained in this study are comparable
to those calculated by Schuster et al. [6] (r = 0.77,
slope = 0.92) and Richard et al. [9] (r = 0.79, slope =
0.79) using PET and 15O-labeled water. Unfortunately,
there is no PBF obtained by CT to compare with our
results [26, 27].
The obtained PBFPET values display a small underesti-
mation compared to PBFMS representing only 10% of
the maximum PBF obtained. The underestimation could
be explained by the difference between the hematocrit of
the blood contained in an arteriole or venule of the ca-
pillary bed (tube hematocrit HT) relative to the
hematocrit of blood entering or leaving it (discharge
hematocrit HD). This difference can be explained by the
Fahraeus effect [33] and results in a decreasing
hematocrit as blood traverses the microvasculature. In
our work, we assumed that HT equals to HD, but a
proper correction would result in an increment of PBF
values as shown in Eq. 8. Pries et al. [34] reported a HT/
HD ratio of 0.65 for HD = 0.3 at 10-μm diameter capillar-
ies. This correction would increase PBF by 15%.
PBF′ ¼ PBF 1−HT
1−HD
ð8Þ
It also has to be noticed that Pearson correlation
values between PBFMS and PBFPET is limited by the
registration inaccuracy between the regions of the in
vivo PET scan and the ex vivo MS measurements. A
possible improvement for this comparison would be the
use of 68Ga-labeled MS that could be quantified by a
PET scan keeping the animal in the same position as in
the 68Ga-DOTA scan.
Another source of error can be the delay between the
AIF derived from the right ventricle and the arrival of
the radiotracer to every tissue voxel [35]. Imprecise de-
lays can produce deviations up to 40% [9]. In this study,
we assumed a constant delay of 2 s, but further improve-
ments can be performed in order to include this delay
time as a free parameter in the non-linear fit. Finally, the
AIF was not corrected by partial volume effect that can
have quantitative effects on the results [36].
Although the animals were studied under basal condi-
tions, a wide variability of heart rate and PBF values was
obtained. This was probably due to the fact that the ani-
mals were mechanically ventilated in pressure support
ventilation mode, which required adjusting the
anesthesia between consecutive scans in order to main-
tain the animal stable under mechanical ventilation.
However, this effect was transient, and all animals
remained stable across each acquisition. In the other
hand, such variations allowed us to explore a wider
range of perfusion values.
Limitations
Despite the promising results, this study was performed
just in normal animals. However, the main possible ap-
plications of this new method are related with the study
of diseased states. As pulmonary flow is related with im-
portant physiologic processes such as gas exchange and
also right ventricle afterload, the ability to track it in a
quantitative and reliable way in usual clinical practice
could potentially improve disease understanding and pa-
tient care. Although non-disease states were studied,
PBF was evaluated in a wide range of values. Also, to the
best of our knowledge, both the tracer behavior itself
and the implemented analysis should remain valid in
pathologic conditions. Based on this, we believe our
PBFPET using
68Ga-DOTA appears as a potential quanti-
tative diagnostic imaging biomarker of endothelial dys-
function in important lung diseases. This, however, still
needs to be proven.
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Another limitation of our study is the small number of
animals (n = 4). However, 57 experiments were used for the
agreement and correlation studies corresponding to the
three scans performed to each animal, and the three trans-
versal regions of each lung. With this, we were able to find
acceptable agreement and good and significant correlation
between PBFPET and the gold standard measurements.
Authors believe that using a larger number of animals
could have improved our results through a decrease in
measured variability, but it is probably unjustified by the
current needs of reducing the number of experimental
animals.
Finally, as most of the current implemented methods,
68Ga-DOTA PBFPET can offer a regional perfusion estima-
tion, which represents a mean value across the entire re-
spiratory cycle. However, mainly due to the volume and
pressure changes within the lungs during the respiration, it
is reasonable to expect that the local perfusion be different
according to the respiratory phase. In this way, dynamic
evaluation of lung perfusion in normal and diseased status
could appear as a promissory research field. This aspect
could be studied with the proposed technique by applying
respiratory synchronization to measured PET data or per-
forming data acquisition during apnea or at the end-of-
expiration. However, this was out of the scope of this study.
Conclusions
In this study, the determination of regional PBF using
68Ga-DOTA PET imaging was proposed, implemented,
and validated. Assessment of PBF with this technique
allows combining the high quantitative accuracy of PET
imaging with the much easier access to 68Ga/68Ge gener-
ators compared to existing techniques using H2
15O that
require an on-site cyclotron. In this way, 68Ga-DOTA
PET appears as a potential method for measuring PBF in
clinical settings with an extended use.
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